Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present China Health Industries Holdings, Inc. (OTC: CHHE).

Full DD Report for CHHE

Recent News from (OTC: CHHE)

Wholly-Owned Subsidiary of China Health Industries Holdings, Inc. Signed an OEM Contract
HARBIN, CHINA / ACCESSWIRE / April 19, 2016 / Harbin Humankind Biology Technology Co., Limited ("Humankind"), the wholly-owned subsidiary of China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries" or "company"), signed a long-term OEM contract with Yantai Baobei Biote...
Source: ACCESSWIRE IA
Date: April, 19 2016 08:08
China Health Industries Holdings, Inc. Achieved Major Technological Breakthrough on Propolis and Black Ant Capsule
Harbin, China--(Newsfile Corp. - April 4, 2016) - China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries" or "company") today announced that the company has achieved a major technological breakthrough on its original product: Propolis and Black Ant Capsule. China ...
Source: Newsfile
Date: April, 04 2016 06:00
China Health Industries Holdings Announces Third Fiscal Quarter Results
China Health Industries Holdings Announces Third Fiscal Quarter Results
Source: OTC Markets
Date: May, 15 2015 00:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-210.4250.480.480.42532,000
2018-04-200.4250.480.480.42532,000
2018-04-190.48750.400.48750.405,600
2018-04-18N/A0.40N/AN/A0
2018-04-17N/A0.40N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-03-02500500100.0000Short
2018-01-311,4009,06015.4525Cover
2017-12-082,5005,00050.0000Short
2017-12-052,5002,500100.0000Short
2017-11-02582582100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report.


About China Health Industries Holdings, Inc. (OTC: CHHE)

Logo for China Health Industries Holdings, Inc. (OTC: CHHE)

The Company, through different subsidiaries, has the license to manufacture and sell health supplement products and another products. In addition, the Company, through its wholly owned subsidiaries, holds one patent for utility models, five patents for external design, and trademarks in China. The Company is licensed to sell its products, including its medical drugs, only in the PRC.

 

Contact Information

 

 

Current Management

  • Xin Sun / CFO, Treasurer
    • Mr. Xin Sun attended Jia Mu Si Medical College with a major in Pharmacy from to . From to , he was the Production Manager at Ha Yao Group Sanchine Medicine JointStock Company Ltd. From to , he was the District Director for the Northeast District of China for Pfizer Pharmaceuticals Limited. Thereafter, he spent one year as the Director of Marketing for Ha Yao Group Sanchine Medicine JointStock Company Ltd. From to , he was the Chief Executive Officer of a company he founded, Heilongjiang Bijie Chemical Industry Co., Ltd., which is no longer in existence now. He obtained his Masters of Business Administration from Renmin University of China in . From to the present, he has been the President and Chief Executive Officer of Humankind. Mr. Sun is also President and General Manager of Huimeijia. As a result of his professional experience, Mr. Xin Sun is well known in the pharmaceutical field in Harbin, PRC. While he was studying at Renmin University, Mr. Xin Sun developed many contacts in the pharmaceutical field, many of which later became district agents and other employees in Humankind s distribution system.
  • Baosen Ma / President, Secretary
  • Elizabeth Fei Chen / Counsel
  • Michelle Arbour / Counsel
  • Xin Sun / Chairman
    • Mr. Xin Sun attended Jia Mu Si Medical College with a major in Pharmacy from to . From to , he was the Production Manager at Ha Yao Group Sanchine Medicine JointStock Company Ltd. From to , he was the District Director for the Northeast District of China for Pfizer Pharmaceuticals Limited. Thereafter, he spent one year as the Director of Marketing for Ha Yao Group Sanchine Medicine JointStock Company Ltd. From to , he was the Chief Executive Officer of a company he founded, Heilongjiang Bijie Chemical Industry Co., Ltd., which is no longer in existence now. He obtained his Masters of Business Administration from Renmin University of China in . From to the present, he has been the President and Chief Executive Officer of Humankind. Mr. Sun is also President and General Manager of Huimeijia. As a result of his professional experience, Mr. Xin Sun is well known in the pharmaceutical field in Harbin, PRC. While he was studying at Renmin University, Mr. Xin Sun developed many contacts in the pharmaceutical field, many of which later became district agents and other employees in Humankind s distribution system.
  • Baosen Ma /
  • Kai Sun /

Current Share Structure

  • Market Cap: $26,215,895 - 03/16/2018
  • Authorized: 300,000,000 - 06/30/2017
  • Issue and Outstanding: 65,539,737 - 09/12/2017
  • Float: 6,304,556 - 12/30/2016

 


Recent Filings from (OTC: CHHE)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: November, 13 2017
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: September, 27 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 17 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2016
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: November, 07 2016
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: October, 28 2016

 

 


Daily Technical Chart for (OTC: CHHE)

Daily Technical Chart for (OTC: CHHE)


Stay tuned for daily updates and more on (OTC: CHHE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CHHE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CHHE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of CHHE and does not buy, sell, or trade any shares of CHHE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us